sector to address the prevention and treatment of HIV

Ensure collaboration, partnership and advocacy
• WHO should promote partnerships between the public sector, civil society and private (for profit and not)
sector to address the prevention and treatment of HIV and STIs among MSM, transgender people and
their partners.
• National AIDS programmes in the ministries of health, with the support of WHO, should build and
strengthen coalitions among civil society and other key stakeholders, including other ministries, to address
the sexual health needs of MSM, transgender people and their partners.
• WHO should take the lead in advocating with other UN agencies and sectors (education, justice, home
affairs, gender, youth, human rights commissions, etc.) on promoting prevention of HIV and STI
transmission among MSM and transgender people, and address homophobia and transphobia, including
in health-care settings.
• WHO, the Joint United Nations Programme on HIV/AIDS (UNAIDS), United Nations Development
Programme (UNDP) and their partners should advocate for the inclusion of interventions to prevent HIV
and STIs among MSM and transgender communities as a part of overall prevention efforts. This can be
done at appropriate events such as ministerial meetings, the World Health Assembly, regional groupings,
among others.
6. Define the role of Regional Offices
• WHO Regional Offices should advocate, disseminate evidence and provide technical assistance to
countries to ensure universal access to HIV prevention, treatment and care for MSM and transgender
populations in all countries in their Regions.
7. Provide resources
• Resources (financial, logistical and human) to support all of the above recommendations must be ensured.
All countries and key funding agencies (including, but not limited to, the Global Fund to fight AIDS, TB and
Malaria) must commit adequate financial and other resources to the prevention, care and treatment of HIV
and other STIs in MSM, transgender people and their partners.
8. Suggested areas for further research
Throughout the consultation, an number of areas were identified, warranting further research which included
assessing the need for provision of human papillomavirus (HPV) vaccination for MSM and transgender
populations, use of rectal microbicides, the role of serosorting and prevention messages in settings where
same-sex relationships are illegal.